Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 68827-43-0 | MDL No. : | MFCD08751343 |
Formula : | C7H10N4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YQQCEOMFCLGSTF-UHFFFAOYSA-N |
M.W : | 150.18 | Pubchem ID : | 10975664 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 4.0 |
Molar Refractivity : | 46.51 |
TPSA : | 101.91 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.52 cm/s |
Log Po/w (iLOGP) : | 0.19 |
Log Po/w (XLOGP3) : | -0.43 |
Log Po/w (WLOGP) : | 0.15 |
Log Po/w (MLOGP) : | 0.4 |
Log Po/w (SILICOS-IT) : | -0.33 |
Consensus Log Po/w : | 0.0 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.84 |
Solubility : | 21.8 mg/ml ; 0.145 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.25 |
Solubility : | 8.54 mg/ml ; 0.0569 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.4 |
Solubility : | 6.05 mg/ml ; 0.0403 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 3.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.09 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
A495771[ 66717-58-6 ]
3,4-Diaminobenzimidamide hydrochloride
Reason: Free-salt
[ 2498-50-2 ]
4-Aminobenzamidine dihydrochloride
Similarity: 0.92
[ 6326-27-8 ]
4-Methylbenzimidamide hydrochloride
Similarity: 0.79
[ 20680-59-5 ]
3-Methylbenzimidamide hydrochloride
Similarity: 0.79
[ 2498-50-2 ]
4-Aminobenzamidine dihydrochloride
Similarity: 0.92
[ 6326-27-8 ]
4-Methylbenzimidamide hydrochloride
Similarity: 0.79
[ 20680-59-5 ]
3-Methylbenzimidamide hydrochloride
Similarity: 0.79
[ 2498-50-2 ]
4-Aminobenzamidine dihydrochloride
Similarity: 0.92
[ 6326-27-8 ]
4-Methylbenzimidamide hydrochloride
Similarity: 0.79
[ 20680-59-5 ]
3-Methylbenzimidamide hydrochloride
Similarity: 0.79